These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 15237)
1. [Monitoring of antitubercular treatments. Value of the determination of serum gamma-glutamyl transpeptidase (gamma-GT)]. Homasson JP; Salignac P; Bonniot JP; Parent G; Angebault M Nouv Presse Med; 1977 Mar; 6(10):858. PubMed ID: 15237 [No Abstract] [Full Text] [Related]
2. [Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)]. Mbaye PS; Talarmin F; Sane M; Eladari D; Klotz F Dakar Med; 1995; 40(2):129-31. PubMed ID: 9827070 [TBL] [Abstract][Full Text] [Related]
3. [Liver damage from tuberculosis treatment]. Keiner F Med Klin; 1981 Jun; 76(13):376-7. PubMed ID: 7254121 [No Abstract] [Full Text] [Related]
4. [Toxicity of antitubercular agents for the liver]. Dölle W Dtsch Med Wochenschr; 1973 Jan; 98(2):74. PubMed ID: 4683834 [No Abstract] [Full Text] [Related]
5. Ethambutol compared to rifampin in original treatment of pulmonary tuberculosis. Bobrowitz ID Lung; 1980; 157(3):117-25. PubMed ID: 7382540 [No Abstract] [Full Text] [Related]
7. [Antitubercular drug-induced liver injuries]. Guo Y; Cui D Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):308-9. PubMed ID: 11326960 [No Abstract] [Full Text] [Related]
8. An unusual recurrence of antitubercular drug induced hepatotoxicity in a child. Bhatia S; Tullu MS; Kannan S; Gogtay NJ; Thatte UM; Lahiri KR J Postgrad Med; 2011; 57(2):147-52. PubMed ID: 21654145 [No Abstract] [Full Text] [Related]
9. [Surveillance and complications of antituberculosis chemotherapy]. Duroux P Rev Prat; 1979 Jun; 29(33):2681-90. PubMed ID: 225779 [No Abstract] [Full Text] [Related]
10. Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis. Guo N; Marra F; Fitzgerald JM; Elwood RK; Marra CA Eur Respir J; 2010 Jul; 36(1):206-8. PubMed ID: 20595167 [No Abstract] [Full Text] [Related]
11. Tuberculosis control programme guidelines--treatment regimens. Durrheim DN; Belt EL S Afr Med J; 1996 Oct; 86(10):1293-4. PubMed ID: 8955740 [No Abstract] [Full Text] [Related]
12. [Treatment of tuberculous praevesical ureteral strictures (author's transl)]. May P; Schindler E Urologe A; 1974 Jan; 13(1):1-5. PubMed ID: 4856813 [No Abstract] [Full Text] [Related]
13. Antitubercular drugs (isoniazid, rifampin and pyrazinamide): hepatobiliary reactions. Vu D; Macdonald L CMAJ; 2001 Oct; 165(7):942-3, 946-7. PubMed ID: 11599338 [No Abstract] [Full Text] [Related]
14. Adverse drug reactions in TB therapy: risks and recommendations. Yoshikawa TT; Nagami PH Geriatrics; 1982 Jul; 37(7):61-8. PubMed ID: 7084671 [No Abstract] [Full Text] [Related]
15. [Treatment of tuberculous meningitis in adults: current trends and problems]. Gallofre López M; Latorre Murillo P; Massons Cirera J; Sumalla Suñe J Rev Clin Esp; 1982 Sep; 166(6):317-9. PubMed ID: 6758078 [No Abstract] [Full Text] [Related]
16. [Drug therapy of pulmonary tuberculosis]. Ludes H Dtsch Med Wochenschr; 1972 Feb; 97(8):289-91. PubMed ID: 5058425 [No Abstract] [Full Text] [Related]
17. Adverse effects of antituberculosis drugs. Girling DJ Drugs; 1982; 23(1-2):56-74. PubMed ID: 6459920 [No Abstract] [Full Text] [Related]
18. [Detection of the effects of the rifampin-isoniazid combination on the human liver]. Plomteux G; Heusghem C; Ferdinande R; Lecoq A; Winandy A; Parmentier JC Nouv Presse Med; 1974 Mar; 3(12):727-32. PubMed ID: 4836506 [No Abstract] [Full Text] [Related]
19. [Hepatotoxic action of rifampicin and isonicotinic acid hydrazide]. Kozma D; Mihalik P; Schaff Z; Lapis K Probl Tuberk; 1982 Jul; (7):68-72. PubMed ID: 7134213 [No Abstract] [Full Text] [Related]